Table 3

Characteristics of PML patients with a history of hematopoietic stem cell transplantation
Patient Age Sex Underlying disease Type of transplant Interval (Days)a
1 50 M Acute myeloid leukemia Allogeneic bone marrow 279
2 44 M Acute lymphoblastic leukemia Allogeneic bone marrow 442
3 42 M Aplastic anemia Allogeneic bone marrow 614
4 58 M Aplastic anemia Allogeneic bone marrow 493
5 43 M Acute myeloid leukemia Umbilical cord blood 450
6 16 M Hodgkin's lymphoma Autologous bone marrow 285
7 61 M Non-Hodgkin's lymphoma Autologous peripheral blood 775
8 52 M Multiple myeloma Autologous peripheral blood 833

M, male.

a Days between transplantation and the initial testing for JCV DNA in CSF specimens.

Nakamichi et al.

Nakamichi et al. BMC Neurology 2012 12:121   doi:10.1186/1471-2377-12-121

Open Data